Using a point-of-care (POC) platform, the investigators will investigate the effects of POC testing for glycated hemoglobin (HbA1c) and cystatin C at out-patient clinics on long-term diabetes outcomes.
Laboratory testing for HbA1c and cystatin C is time-consuming, and healthcare providers often do not have update results when they evaluate outpatients with diabetes. A POC testing platform may help address this issue, and the investigators aim to examine its effects on diabetes outcomes.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
222
POC testing for HbA1c and cystatin C
Taichung Veterans General Hospital
Taichung, Taiwan
Changes from baseline to the end of study in eGFR
Estimated glomerular filtration rate (eGFR) will be determined using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (Levey AS, et al. Ann Intern Med. 2009; 150: 604-12).
Time frame: Observational follow up period of 3 years
Changes from baseline to the end of study in UACR
Time frame: Observational follow up period of 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.